spot_img
Saturday, July 2, 2022
More
    HomeHealthFDA’s Pazdur on accelerated approval, single-arm studies, and his future

    FDA’s Pazdur on accelerated approval, single-arm studies, and his future

    -



    CHICAGO — When most cancers medication granted accelerated approval within the U.S. later prove to not profit sufferers, the Meals and Drug Administration would favor drugmakers take away them from the market voluntarily. However only a few firms are keen to do this, which generally forces Richard Pazdur, the company’s prime most cancers drug regulator, to select up the cellphone and have a blunt dialog with drug firm executives.

    “Peggy Hamburg, a former FDA commissioner, gave me a phrase that I usually use — in case you don’t see the sunshine, you’ll quickly really feel the warmth,” Pazdur mentioned Friday night, talking at a STAT occasion through the annual assembly of the American Society of Medical Oncology.

    Unlock this text by subscribing to STAT+ and revel in your first 30 days free!

    GET STARTED





    Source link

    Related articles

    Stay Connected

    0FansLike
    0FollowersFollow
    3,377FollowersFollow
    0SubscribersSubscribe
    spot_img

    Latest posts